Medication info

Rithain Injection 4% (Lidocaine Hydrochloride)

Prescription medicationSolutionIntravenous injectionExpired
Ingredient · strength
Lidocaine Hydrochloride Hydrate›42.66mg / 1mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
Colorless, transparent solution filled in a colorless, transparent vial
Packaging
10 vials/box (20 mL/vial)
Approval status
Expired

MFDS item code 199100312 · Notified 1991.07.23 · Insurance code 645101341

This product's status changed to Expired on 2025.10.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Local anesthesia and lubrication; relief of pain and suppression of nausea; treatment of ventricular arrhythmias
Who receives it
Adults
Adult administration
(Solution: 2% viscous) Adults: The recommended maximum single dose for healthy adults is 4.5㎎/㎏ body weight as lidocaine hydrochloride, and under no circumstances should the total dose exceed 300㎎ (15㎖ of this product) as lidocaine hydrochloride. For symptomatic treatment of irritation or inflammation of the oral and pharyngeal mucosa, administer 300㎎ (15㎖ of this product) as lidocaine hydrochloride. For oral use, hold this product in the mouth and then spit it out; for pharyngeal use, it may be swallowed after being held in the mouth. Do not use again within 3 hours, and do not use more than 8 times within 24 hours. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Gel: 2%) ○ Adults 1. Urethral anesthesia 1) Surface anesthesia of the male urethra: Instill 20 ㎖ (400㎎ as lidocaine hydrochloride), slowly inserting 10 ㎖ (200㎎ as lidocaine hydrochloride) of this product, and apply a penile clamp to the corona for several minutes before instilling the remainder. When anesthesia is particularly important, such as for catheterization or cystoscopy, a larger amount (e.g., 30-40㎖ of this product) may be administered in 3-4 divided applications. 2) Surface anesthesia of the female urethra: Instill 5-10㎖ (100-200㎎ as lidocaine hydrochloride) of this product. 2. During endoscopic examination: Instill 10-20㎖ (200-400㎎ as lidocaine hydrochloride) of this product. For lubrication, apply a small amount to the instrument. 3. Lubrication for tracheal intubation: Immediately before insertion, apply about 5㎖ (100㎎ as lidocaine hydrochloride) of this product to the surface of the tube. Take care to prevent this product from entering the tube. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 0.5% for intramuscular use) Adults: Using the solvent for intramuscular use, administer 10-15㎎ as lidocaine hydrochloride by intramuscular injection. Never use for intravenous injection. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 1%) [Anesthesia] ○ Adults 1. Epidural anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 100-200㎎ 2. Conduction anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 30-200㎎; 30-100㎎ for digital nerve block, and up to 50㎎ for intercostal nerve block 3. Infiltration anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 20-200㎎ 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. [Medical use] ○ Adults 1. Single intravenous administration: Slowly inject 50-100㎎ (1-2㎎/㎏) as lidocaine hydrochloride intravenously over 1-2 minutes. If no effect is observed, administer the same dose after 5 minutes. If prolongation of the effect is desired, the same dose may also be administered at 10-20-minute intervals; however, the standard maximum dose within 1 hour is 300㎎. 2. Intravenous infusion: If a single intravenous dose is effective and prolongation of the effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject intravenously at a rate of 1-2㎎ per minute as lidocaine hydrochloride. The rate may be increased if necessary, but the maximum rate is 4㎎ per minute. (Injection: 2%) [Anesthesia] ○ Adults 1. Epidural anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 200㎎ 2. Conduction anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 40-200㎎; 60-120㎎ for digital nerve block 3. Infiltration anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 40-200㎎ 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. [Medical use] ○ Adults 1. Single intravenous administration: Slowly inject 50-100㎎ (1-2㎎/㎏) as lidocaine hydrochloride intravenously over 1-2 minutes. If no effect is observed, administer the same dose after 5 minutes. If prolongation of the effect is desired, the same dose may also be administered at 10-20-minute intervals; however, the standard maximum dose within 1 hour is 300㎎. 2. Intravenous infusion: If a single intravenous dose is effective and prolongation of the effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject intravenously at a rate of 1-2㎎ per minute as lidocaine hydrochloride. The rate may be increased if necessary, but the maximum rate is 4㎎ per minute. (Injection: 0.5%) ○ Adults 1. Epidural anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 25-150㎎; 25-100㎎ for sympathetic nerve block 2. Conduction anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 15-200㎎; 15-50㎎ for digital nerve block, and up to 25㎎ for intercostal nerve block 3. Infiltration anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 10-200㎎ 4. Intravenous regional anesthesia of the extremities: Do not exceed 200㎎ as bupivacaine hydrochloride. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 4%) ○ Adults 1. Surface anesthesia (for use on mucous membranes such as the mouth, pharynx, airway, and urethra): The maximum single dose for healthy adults is 4.5㎎/㎏ body weight as lidocaine hydrochloride, and the total dose should not exceed 300㎎ as lidocaine hydrochloride. Apply or spray an appropriate amount, referring to the following. 1) For local anesthesia via a transtracheal approach during bronchoscopy, inject 80-120㎎ (2-3㎖ of this product) as lidocaine hydrochloride through a sufficiently large needle to allow rapid injection. The pharynx may sometimes be sprayed to achieve complete analgesia, but the total amount administered by injection and spray should not exceed 200㎎ (5㎖ of this product) as lidocaine hydrochloride or 3㎖/㎏ body weight. 2) Topical application: Spray 40-200㎎ (1-5㎖ of this product) as lidocaine hydrochloride into the pharynx during laryngopharyngeal examination, bronchoscopy, and endotracheal intubation. 2. Epidural anesthesia, conduction anesthesia, and infiltration anesthesia (diluted to 0.5~2%): The standard maximum dose is 200㎎ per dose as lidocaine hydrochloride. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Local anesthesia and lubrication; relief of pain and suppression of nausea; treatment of ventricular arrhythmias

  • Irritation of oral mucosa
  • irritation of pharyngeal mucosa
  • inflammation of oral mucosa
  • inflammation of pharyngeal mucosa
  • gag reflex
  • pain from cystitis
  • pain from urethritis
  • pain
View approved original text

This medication is used in various forms, and its effectiveness varies according to each indication. The liquid form of the 2% viscous preparation is used in otorhinolaryngology for local anesthesia in cases of irritation and inflammation of the oral and pharyngeal mucosa and is used in dentistry to suppress gag reflex during X-ray imaging or dental impressions. The 2% gel formulation provides surface anesthesia and lubrication, used during cystoscopy, catheter insertion, urethral surgeries, endoscopy, proctoscopy, and intubation, helping to relieve pain from cystitis or urethritis. The injection formulation varies depending on the concentration and use, with the 0.5% intramuscular injection relieving pain during antibiotic injections. The 1% and 2% injections are used for epidural anesthesia, nerve block, infiltration anesthesia, surface anesthesia, and also in the treatment of ventricular arrhythmias, while the 0.5% injection is also used for anesthesia purposes. The 4% injection is used for surface anesthesia and can be diluted for various anesthesia types. Thus, this medication is used for various anesthesia and pain relief applications.

How it is given

Adult administration

(Solution: 2% viscous) Adults: The recommended maximum single dose for healthy adults is 4.5㎎/㎏ body weight as lidocaine hydrochloride, and under no circumstances should the total dose exceed 300㎎ (15㎖ of this product) as lidocaine hydrochloride. For symptomatic treatment of irritation or inflammation of the oral and pharyngeal mucosa, administer 300㎎ (15㎖ of this product) as lidocaine hydrochloride. For oral use, hold this product in the mouth and then spit it out; for pharyngeal use, it may be swallowed after being held in the mouth. Do not use again within 3 hours, and do not use more than 8 times within 24 hours. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Gel: 2%) ○ Adults 1. Urethral anesthesia 1) Surface anesthesia of the male urethra: Instill 20 ㎖ (400㎎ as lidocaine hydrochloride), slowly inserting 10 ㎖ (200㎎ as lidocaine hydrochloride) of this product, and apply a penile clamp to the corona for several minutes before instilling the remainder. When anesthesia is particularly important, such as for catheterization or cystoscopy, a larger amount (e.g., 30-40㎖ of this product) may be administered in 3-4 divided applications. 2) Surface anesthesia of the female urethra: Instill 5-10㎖ (100-200㎎ as lidocaine hydrochloride) of this product. 2. During endoscopic examination: Instill 10-20㎖ (200-400㎎ as lidocaine hydrochloride) of this product. For lubrication, apply a small amount to the instrument. 3. Lubrication for tracheal intubation: Immediately before insertion, apply about 5㎖ (100㎎ as lidocaine hydrochloride) of this product to the surface of the tube. Take care to prevent this product from entering the tube. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 0.5% for intramuscular use) Adults: Using the solvent for intramuscular use, administer 10-15㎎ as lidocaine hydrochloride by intramuscular injection. Never use for intravenous injection. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 1%) [Anesthesia] ○ Adults 1. Epidural anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 100-200㎎ 2. Conduction anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 30-200㎎; 30-100㎎ for digital nerve block, and up to 50㎎ for intercostal nerve block 3. Infiltration anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 20-200㎎ 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. [Medical use] ○ Adults 1. Single intravenous administration: Slowly inject 50-100㎎ (1-2㎎/㎏) as lidocaine hydrochloride intravenously over 1-2 minutes. If no effect is observed, administer the same dose after 5 minutes. If prolongation of the effect is desired, the same dose may also be administered at 10-20-minute intervals; however, the standard maximum dose within 1 hour is 300㎎. 2. Intravenous infusion: If a single intravenous dose is effective and prolongation of the effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject intravenously at a rate of 1-2㎎ per minute as lidocaine hydrochloride. The rate may be increased if necessary, but the maximum rate is 4㎎ per minute. (Injection: 2%) [Anesthesia] ○ Adults 1. Epidural anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 200㎎ 2. Conduction anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 40-200㎎; 60-120㎎ for digital nerve block 3. Infiltration anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 40-200㎎ 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. [Medical use] ○ Adults 1. Single intravenous administration: Slowly inject 50-100㎎ (1-2㎎/㎏) as lidocaine hydrochloride intravenously over 1-2 minutes. If no effect is observed, administer the same dose after 5 minutes. If prolongation of the effect is desired, the same dose may also be administered at 10-20-minute intervals; however, the standard maximum dose within 1 hour is 300㎎. 2. Intravenous infusion: If a single intravenous dose is effective and prolongation of the effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject intravenously at a rate of 1-2㎎ per minute as lidocaine hydrochloride. The rate may be increased if necessary, but the maximum rate is 4㎎ per minute. (Injection: 0.5%) ○ Adults 1. Epidural anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 25-150㎎; 25-100㎎ for sympathetic nerve block 2. Conduction anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 15-200㎎; 15-50㎎ for digital nerve block, and up to 25㎎ for intercostal nerve block 3. Infiltration anesthesia (standard maximum dose: 200㎎ per dose as lidocaine hydrochloride): 10-200㎎ 4. Intravenous regional anesthesia of the extremities: Do not exceed 200㎎ as bupivacaine hydrochloride. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 4%) ○ Adults 1. Surface anesthesia (for use on mucous membranes such as the mouth, pharynx, airway, and urethra): The maximum single dose for healthy adults is 4.5㎎/㎏ body weight as lidocaine hydrochloride, and the total dose should not exceed 300㎎ as lidocaine hydrochloride. Apply or spray an appropriate amount, referring to the following. 1) For local anesthesia via a transtracheal approach during bronchoscopy, inject 80-120㎎ (2-3㎖ of this product) as lidocaine hydrochloride through a sufficiently large needle to allow rapid injection. The pharynx may sometimes be sprayed to achieve complete analgesia, but the total amount administered by injection and spray should not exceed 200㎎ (5㎖ of this product) as lidocaine hydrochloride or 3㎖/㎏ body weight. 2) Topical application: Spray 40-200㎎ (1-5㎖ of this product) as lidocaine hydrochloride into the pharynx during laryngopharyngeal examination, bronchoscopy, and endotracheal intubation. 2. Epidural anesthesia, conduction anesthesia, and infiltration anesthesia (diluted to 0.5~2%): The standard maximum dose is 200㎎ per dose as lidocaine hydrochloride. Adjust the dose as appropriate according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition.

Precautions

This medication should not be used in patients with severe bleeding or shock, patients with inflammation at the injection site or sepsis, and patients who are allergic to this medication or other amide-type local anesthetics. Caution is required when administering to patients with central nervous system disorders, pregnant women, elderly individuals, patients with severe hypertension, and patients with severe spinal deformities. Serious reactions such as shock, drop in blood pressure, abnormal pulse, and respiratory depression may occur while using this medication, so the patient should be closely monitored, and if any abnormal symptoms appear, administration should be immediately stopped, and appropriate treatment should be received. Furthermore, a serious side effect called malignant hyperthermia can rarely occur, so if there is a sudden increase in body temperature, muscle rigidity, or blood discoloration, administration should be stopped immediately, and professional treatment should be sought. Central nervous system symptoms may include tremors, seizures, drowsiness, anxiety, dizziness, and nausea, which should be promptly treated if they occur. This medication can cause allergic reactions like skin rashes or swelling and, in severe cases, anaphylaxis, so any unusual symptoms should be reported to the healthcare provider immediately. During the use of local anesthetics, sudden shock or symptoms of poisoning can occur, so preparations for emergency treatment are always necessary. Careful observation of the patient's general condition is required during administration, using the lowest effective concentration and minimum dose possible, particularly being cautious when used in conjunction with vasoconstrictors. Especially when injected in highly vascular areas, the absorption is rapid, so it is recommended to use only a small volume. Ensure that the injection needle does not enter blood vessels or spinal fluid, and it is advisable to administer slowly if possible. This medication should not be used in conjunction with certain vasoconstrictors, and caution is necessary when combined with some drugs, as it may lead to cardiac function suppression or increased toxicity. The safety of this medication in pregnant women has not been established, so it should only be used when the benefits of treatment outweigh the risks. Elderly individuals may be more sensitive to the effects of the drug, so dosage adjustments and monitoring of the patient's condition are important. Lastly, the metabolites of this medication cannot be excluded from the possibility of causing mutations or tumor development with prolonged high-dose use, so it is advisable not to administer at high concentrations for extended periods.

Side effects

  • shock
  • hypotension
  • facial pallor
  • pulse abnormalities
  • respiratory depression
  • malignant hyperthermia
  • tachycardia
  • arrhythmia
  • blood pressure fluctuations
  • sudden increase in temperature
Show 20 more
  • muscle rigidity
  • blood's dark red coloration
  • cyanosis
  • hyperventilation
  • sweating
  • acidosis
  • hyperkalemia
  • myoglobinuria
  • tremors
  • seizures
  • drowsiness
  • anxiety
  • agitation
  • neglect
  • dizziness
  • nausea
  • vomiting
  • urticaria
  • edema
  • anaphylactic reaction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. By storing it this way, the efficacy of the drug can be maintained and degradation prevented.

Appearance and packaging

Appearance

Colorless, transparent solution filled in a colorless, transparent vial

Package unit

10 vials/box (20 mL/vial)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.